Drugs News and Research

RSS

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).

25 Feb 2014

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

A pathway to more effective and efficient synthesis of pharmaceutical drugs and other flow reactor chemical products has been opened by a study in which for the first time the catalytic reactivity inside a microreactor was mapped in high resolution from start-to-finish.

25 Feb 2014

Experts find that chances of heart or stroke attack doubles after partner's death

Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.

25 Feb 2014

New report reveals prevalence of heroin-related overdose deaths in Kentucky

A new report from the Kentucky Injury Prevention and Research Center (KIPRC) reveals the prevalence and charges associated with drug overdose in the Bluegrass state.

25 Feb 2014

Regulators propose 1.9% cut to Medicare advantage payments

Federal regulators late Friday proposed cutting payments to private Medicare plans by 1.9 percent after recent lower health care spending growth. Insurers worry the cut could be much deeper than that after health law fees and other payment changes take effect, however, and say another cut could affect benefits for seniors.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

UCLA scientists developed experimental treatment that eradicates acute type of leukemia in mice

A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.

25 Feb 2014

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke.

25 Feb 2014

New class of drugs developed to treat cancer, reduces sudden cardiac death risk after heart attack

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a new class of drugs, originally developed to treat cancer, reduces sudden cardiac death risk after a heart attack. The findings were published online in advance of print in the Journal of the American College of Cardiology.

25 Feb 2014

New research shows that saturated fat builds more fat, less muscle than polyunsaturated fat

New research from Uppsala University shows that saturated fat builds more fat and less muscle than polyunsaturated fat. This is the first study on humans to show that the fat composition of food not only influences cholesterol levels in the blood and the risk of cardiovascular disease but also determines where the fat will be stored in the body.

25 Feb 2014

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

Novel two-pronged strategy targeting DNA synthesis treats leukemia in mice

A novel two-pronged strategy targeting DNA synthesis can treat leukemia in mice, according to a study in The Journal of Experimental Medicine.

25 Feb 2014

IRSF announces new research grants for translational research program and clinical trials

The International Rett Syndrome Foundation (IRSF) announces today ten (10) new research grants at leading global research institutions; a new Translational Research Program; and additional funding for current human clinical trials.

24 Feb 2014

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.

24 Feb 2014

Combining Nanophotonics and Microfluidics for the Characterization of Nanoparticles

In this interview, Bernardo Cordovez describes the development of a new nanophotonic chip that can be used to characterize nanoparticles.

From Halo Labs 24 Feb 2014

First Edition: February 24, 2014

Today's headlines include continuing coverage of Medicare Advantage payment rates, as well as a range of stories about the health law's Medicaid expansion and online insurance marketplaces.

24 Feb 2014

Research roundup: Palliative care and ACOs; employers and Supreme Court case on contraception

In preparation for the new ACO environment, leaders recognized the contribution palliative care can make to health care "value," especially in the care of our sickest (and most expensive) patients ...

24 Feb 2014

Rural physicians more likely to discuss costs of care with patients, involve in quality improvement activities

The increased demand for primary care services expected to result from the Affordable Care Act (ACA) may be felt strongly in rural areas. While studies have found that the quality of care delivered to rural patients is as good or better than that available in urban areas, the belief persists that top-quality primary care is only available in big cities.

24 Feb 2014

New system delivers anti-inflammatory drugs to immune cells gone out of control

Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. Their findings were published online Feb. 23 in Nature Nanotechnology.

24 Feb 2014

Researchers clear up one aspect of how bowels move

High performance athletes like Olympians can push their bodies to optimal potential, but some of the ways the human body actually works is still a mystery.

24 Feb 2014

Drugs News and Research

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

Experts find that chances of heart or stroke attack doubles after partner's death

New report reveals prevalence of heroin-related overdose deaths in Kentucky

Regulators propose 1.9% cut to Medicare advantage payments

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

UCLA scientists developed experimental treatment that eradicates acute type of leukemia in mice

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

New class of drugs developed to treat cancer, reduces sudden cardiac death risk after heart attack

New research shows that saturated fat builds more fat, less muscle than polyunsaturated fat

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Novel two-pronged strategy targeting DNA synthesis treats leukemia in mice

IRSF announces new research grants for translational research program and clinical trials

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

Combining Nanophotonics and Microfluidics for the Characterization of Nanoparticles

First Edition: February 24, 2014

Research roundup: Palliative care and ACOs; employers and Supreme Court case on contraception

Rural physicians more likely to discuss costs of care with patients, involve in quality improvement activities

New system delivers anti-inflammatory drugs to immune cells gone out of control

Researchers clear up one aspect of how bowels move

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News